HIA
AVXL icon

Harbor Investment Advisory’s Anavex Life Sciences AVXL Stock Holding History

Harbor Investment Advisory’s Portfolio AVXL Stock Details AVXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-1,000
Closed -$12K – 1336
2022
Q1 		$12K Hold
1,000
– – ﹤0.01% 1026
2021
Q4 		$17K Buy
+1,000
New +$19K ﹤0.01% 960

Other funds holding AVXL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
PC
Pier Capital Stamford, Connecticut $755M AUM 94.38% 1-Year Est. Return

Harbor Investment Advisory's AVXL Position: Q2 2022 in Review

Harbor Investment Advisory sold out of Anavex Life Sciences (AVXL) in Q2 2022, closing a stake of 1,000 shares — an estimated $12K sold.

Harbor Investment Advisory first reported a position in AVXL in Q4 2021 and held it in 2 quarters. The position peaked at $17K in Q4 2021. 150 funds tracked by Wall St. Rank hold AVXL as of Q2 2022.

  • Harbor Investment Advisory reported no remaining Anavex Life Sciences position as of Q2 2022 after selling out during the quarter.
  • Harbor Investment Advisory sold 1,000 Anavex Life Sciences shares in Q2 2022, an estimated $12K.
  • Harbor Investment Advisory first reported a position in Anavex Life Sciences in Q4 2021 and held it in 2 quarters.
  • Harbor Investment Advisory's Anavex Life Sciences position peaked at $17K in Q4 2021.
  • 150 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q2 2022.

Based on Harbor Investment Advisory's 13F filing for Q2 2022, filed 18 Jul 2022.